Gated single-photon emission computed tomography detects subendocardial ischemia in hypertrophic cardiomyopathy

Tatsuya Kawasaki1, Yoshiki Akakabe, Michiyo Yamano

  • 1Department of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan. js-k@wf6.so-net.ne.jp

Insights

Gated single-photon emission computed tomography (SPECT) effectively detects exercise-induced subendocardial ischemia (SEI) in hypertrophic cardiomyopathy (HCM) patients. Changes in left ventricular end-systolic volume are key indicators for identifying SEI during exercise.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) can lead to subendocardial ischemia (SEI) in the left ventricle (LV).
  • Assessing exercise-induced SEI in HCM patients is crucial for management.

Purpose of the Study:

  • To evaluate the utility of volumetric variables from gated single-photon emission computed tomography (SPECT) in detecting exercise-induced SEI.
  • To determine if SPECT-derived volumetric data can identify SEI in HCM patients.

Main Methods:

  • Exercise 99mTc-tetrofosmin myocardial scintigraphy performed on 26 HCM patients.
  • Quantification of SEI and correlation with volumetric variables using Quantitative Gated SPECT software.
  • Analysis of exercise-induced percentage changes in LV end-systolic and end-diastolic volumes.

Main Results:

  • HCM patients with SEI showed a significantly higher exercise-induced percentage change in LV end-systolic volume (25.8%) compared to those without (10.0%).
  • No significant difference in LV end-diastolic volume changes was observed between groups.
  • An optimal cutoff of 17% change in LV end-systolic volume demonstrated 89% sensitivity and 82% specificity for SEI detection.

Conclusions:

  • Gated SPECT is a valuable tool for detecting exercise-induced SEI in a specific group of HCM patients.
  • Left ventricular end-systolic volume changes are reliable indicators of SEI during exercise in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...